scai promotes dna double-strand break repair in distinct ... · scai-deleted (ko) u2os cells were...
TRANSCRIPT
NATURE CELL BIOLOGY
Correction noticeNature Cell Biology 18, http://dx.doi.org/10.1038/ncb3436 (2016).
SCAI promotes DNA double-strand break repair in distinct chromosomal contexts
Rebecca Kring Hansen, Andreas Mund, Sara Lund Poulsen, Maria Sandoval, Karolin Klement, Katerina Tsouroula, Maxim A. X. Tollenaere, Markus Räschle, Rebeca Soria, Stefan Offermanns, Thomas Worzfeld, Robert Grosse, Dominique T. Brandt, Björn Rozell, Matthias Mann, Francesca Cole, Evi Soutoglou, Aaron A. Goodarzi, Jeremy A. Daniel, Niels Mailand and Simon Bekker-Jensen
In the original version of this file posted online, Supplementary Figure 4 was duplicated and incorrectly appeared as Supplementary Figures 3 and 4. This was corrected in this file on 17 November 2016.
© 2016
Macmillan
Publishers
Limited,
part
of
Springer
Nature.
All
rights
reserved.
S U P P L E M E N TA RY I N F O R M AT I O N
WWW.NATURE.COM/NATURECELLBIOLOGY 1
DOI: 10.1038/ncb3436
Hansen et al, Figure S1 a
f
c
e
d
−SCAI −MCM6
siCTRL si#9 si#10
g U2OS
γ-H2AX 53BP1 merge γ-H2AX 53BP1 merge Mock IR – 5 Gy, 1 h
siC
TRL
siSC
AI #
9 si
SCAI
#10
i
CH
R
−SCAI (1H2)
Soluble CHR WT WT KO KO
−Tubulin
−SP1
U2OS
50-
55-
98-
98- 55-
U2OS/ S-HA-SCAI
+ DOX −53BP1 −53BP1 −S-HA- SCAI In
put
PD:
Stre
p
65- 220-
220-
IR (5 Gy, 4 h)
U2O
S / G
FP-S
CAI
No IR
siCTRL siCTRL si53BP1
U2OS/GFP-SCAI γ-H2AX GFP-SCAI merge
moc
k M
G13
2
b
h
U2OS/GFP-SCAI γ-H2AX GFP-SCAI merge
siC
TRL
si53
BP1
Supplementary Figure 1 SCAI is enriched on DNA damage-containing chromatin and interacts with 53BP1. a. Protein intensity of SCAI on psoralen (PSO)-crosslinked (red) or undamaged chromatin (blue) plotted against time. Data was replotted from 1. b. Protein intensity of SCAI on psoralen-crosslinked chromatin in the absence (red) or presence of the replication inhibitor geminin (GEM) (black) plotted against time. Data was replotted from 1. c. Soluble and chromatin-enriched (CHR) fractions of lysates from WT and SCAI-deleted (KO) U2OS cells were analyzed by immunoblotting with the indicated antibodies. d. U2OS cells were treated with doxycycline (DOX) to induce expression of Strep-HA-tagged SCAI, and SCAI-containing complexes were isolated by Strep-tactin pull-down from total cell lysates. Associated proteins were analyzed by immunoblotting with antibodies to 53BP1 and HA. e. U2OS cells stably expressing GFP-SCAI transfected with control (CTRL)
or 53BP1 siRNAs were subjected to laser micro-irradiation, fixed 1 h later and immunostained with γ-H2AX antibody. f. U2OS cells stably expressing GFP-SCAI were transfected with control (CTRL) or 53BP1 siRNA, exposed to ionizing radiation (IR, 5 Gy) as indicated and fixed 4 h later. g. U2OS cells were transfected with control (CTRL) or one of two independent SCAI siRNAs (si#9, si#10). Chromatin-enriched fractions of the cells were analyzed by immunoblotting with antibodies against SCAI and MCM6. h. U2OS cells stably expressing GFP-SCAI (U2OS/GFP-SCAI) were treated with proteasome inhibitor MG132 for 3 h and subjected to laser micro-irradiation. Cells were fixed after 1 h and immunostained with γ-H2AX antibody. i. Cells from (g) were exposed to ionizing radiation (IR, 5 Gy) as indicated, fixed 1 h later and immunostained with antibodies against 53BP1 and γ-H2AX. All scale bars, 10 μm. Uncropped blots (c,d,g) are shown in Figure S6
S U P P L E M E N TA RY I N F O R M AT I O N
2 WWW.NATURE.COM/NATURECELLBIOLOGY
aHansen et al, Figure S2
bRecruitment of SCAI to DSB-surrounding chromatin
Yes
Yes
No
Yes
N-term
S28A
WT
BRCT
19721
53BP1
Tandem BRCTP Tudor UDR
Focus forming region
ATM-P region
P P P
17091
53BP1PP P P
1972921
53BP1
19721
53BP1A A A A A
siBR
CA2
U2OS/GFP-SCAI + MG132, extracted
siC
TRL
siBR
CA1
-H2AX GFP merge
d
si53
BP1
siC
TRL
siSC
AI
-H2AXRIF1 merge
e
GST
GST-SCAIGST
Biotin-ssDNA oligoStreptavidin PDInput
28-
62-
98-+
++ +
+
+ +
GST-SCAI
Untagged ssDNA oligo+
c
GFP
-SC
AI
siCTRL si53BP1 siRNF8
Chromatin compartment
ssDNA compartment
UbUb
RP ARP A R P
RP ARPAPUbUb
P
U2OS/GFP-SCAI, extracted
Supplementary Figure 2 53BP1-dependent and -independent recruitment of SCAI to DNA damage sites. a. Schematic representation of human 53BP1 constructs used in the complementation assay in (Figure 2a). WT; wild type, ΔBRCT; deletion of tandem BRCT domains; ΔN-term; deletion of N-terminus, S28A; alanine substitution of all putative N-terminal ATM phosphorylation sites. Ability to support SCAI recruitment when transfected into 53BP1-/- MEFs is indicated for each construct on the right. b. U2OS cells transfected with control (CTRL) or siRNA targeting SCAI or 53BP1 were subjected to laser micro-irradiation, fixed 1 h later and immunostained with antibodies against RIF1 and γ-H2AX. c. U2OS/GFP-SCAI cells were transfected with control (CTRL), 53BP1 or RNF8 siRNAs, subjected to laser micro-irradiation, and pre-extracted and fixed 1 h later. Inserts show larger magnifications of the highlighted nuclear regions, revealing accumulation of SCAI in the DSB-surrounding chromatin compartment dependent on 53BP1 and RNF8, and in the ssDNA compartment, independently of
53BP1 and RNF8. Lower panel: Schematic of compartmentalization of IRIF. “Chromatin compartment” denotes regions of DDR-modified chromatin, into which 53BP1 accumulates and recruits SCAI. “ssDNA compartment” denotes areas of resected DNA to which SCAI is recruited by a 53BP1-independent mechanism. d. U2OS/GFP-SCAI cells were transfected with control (CTRL) or siRNAs targeting BRCA1 or BRCA2, and treated with proteasome inhibitor MG132 for 3 h to interfere with ubiquitin-dependent recruitment of SCAI and 53BP1 to chromatin regions. Cells were the subjected to laser micro-irradiation, pre-extracted and fixed 1 h later and immunostained with γ-H2AX antibody. All scale bars, 10 μm. e. SCAI interacts with ssDNA. Untagged or Biotinylated ssDNA oligos were incubated with purified GST or GST-SCAI as indicated and subjected to pull-down (PD) with Streptavidin beads. Beads were washed extensively and resolved on SDS-PAGE along with input (5%) samples. Uncropped blots (e) are shown in Figure S6.
S U P P L E M E N TA RY I N F O R M AT I O N
WWW.NATURE.COM/NATURECELLBIOLOGY 3
Supplementary Figure 3 SCAI is required for optimal DSB repair but is dispensable for accrual of HR factors. a. U2OS cells (WT) or derivate lines with targeted knockout of SCAI (SCAI KO) and reconstituted expression of ectopic SCAI (rescue) were incubated in the presence of EdU, exposed to IR (1Gy) and fixed at the indicated time points. Cell cycle position of individual cells was determined by detection of EdU and DAPI signal. b. U2OS cells lacking SCAI (SCAI KO) were obtained by CRISPR-mediated knockout and used to generate a derivative cell line in which expression of SCAI was stably reconstituted (‘rescue’). Chromatin-enriched fractions of these cell lines were analyzed by immunoblotting with SCAI and MCM6 antibodies. c. U2OS cells deleted for 53BP1 were generated by CRISPR-mediated knockout. Lysates from parental and 53BP1 KO derivatives of U2OS cells were analyzed by immunoblotting with 53BP1 and MCM6 antibodies. d. U2OS cells and derivative cell lines from Figure S3b were fixed at indicated times after exposure to IR (1 Gy) and stained with 53BP1 antibody. The number of foci per cell was measured by high content microscopy. Centre indicates the median and whiskers the borders of the 95% quantiles. 1000 cells (n= 1000 independent measurements) were measured per condition and p-values were calculated from a non-parametric two-tailed Mann-Whitney U test. e. Parental U2OS cells and two independently derived derivative lines with targeted SCAI knockout were co-transfected with either circular (negative control) or linearized GFP-NHEJ reporter plasmid and construct encoding RFP. Cells
were analyzed by flow cytometry for GFP and RFP positivity 48 h later, and the proportion of GFP-/RFP-positive cells compared to RFP positive cells only cells was determined. The NHEJ efficiency of WT cells was set to 1. Values indicate the mean and error bars the standard deviation from 3 independent experiments (n=3). P-values were calculated from a two-tailed t-test. f. Cells from Figure 3b were treated and analyzed as in (e), expect cells were transfected with either circular or linearized GFP-HR reporter plasmid. The HR efficiency of WT cells was set to 1. Error bars indicate the standard deviation from 3 independent experiments (n=3) and P-values were calculated from a two-tailed t-test. g. U2OS WT and SCAI KO cells were exposed to IR, fixed 6 h later and immunostained with antibodies against RAD51 and γ-H2AX. h. As in (g), except that WT or SCAI-/- MEFs and the indicated dose of IR were used. All scale bars, 10 μm. i. Analysis of RAD51 foci in WT and SCAI-/- primary MEFs at different cell cycle stages. Cells were incubated in the presence of EdU for 1 h, exposed to IR and fixed after another 3.5 h, then immunostained with RAD51 antibody and counterstained for EdU and DAPI. Cells were analyzed by automated high-content microscopy using EdU positivity to identify S phase cells and DAPI intensity to discriminate between G1 and G2 phase in EdU-negative cells. Four individual MEF preparations were analyzed for each genotype (n=4 biologically independent samples), and 1500 cells were analyzed per sample. Values indicate the mean and error bars are the standard deviation. Uncropped blots (b,c) are shown in Figure S6.
0102030405060708090
100
Cou
nt %
(Cel
l cyc
le)
0 5’ 1 24 0 5’ 1 24 0 5’ 1 24
KO WT Rescue Time after IR (1Gy)
Hansen et al, Figure S3
b
f
a
c
no IR 4 Gy10
Gy
no IR 4 Gy10
Gy
0.0
4.0×103
8.0×103
1.2×104
1.6×104
2.0×104
Tota
l int
ensi
ty o
f RA
D51
foci
per n
ucle
us
G1SG2/M
WT SCAI-/-
h 5 Gy IR – 6h
RAD51 γ-H2AX merge
SCAI
KO
WT
d e
i
−53BP1
WC
E
−MCM6
WT KO A5
220-
98-
−SCAI
−MCM6 CH
R
U2O
S
rescue
U2OS / SCAI KO
+
98-
55-
g
WT
SCAI
-/-
RAD51 10 Gy–3.5 h
f
WT
SCAI KO #4
SCAI KO #7
0.0
0.2
0.4
0.6
0.8
1.0
1.2
Repa
ir effi
cien
cy
p=0.021 HR reporter
WT
SCAI KO#4
SCAI KO#7
0.0
0.2
0.4
0.6
0.8
1.0
1.2
Repa
ir effi
cien
cy p=0.006 p=0.004
NHEJ reporter
0.0 2.5 5.0 7.5 10.0 12.5 15.0 17.5 20.0 22.5 25.0 27.5 30.0 32.50
10
20
30
40
50
60
70
Foci
cou
nt 5
3BP1
0 5’ 1 24 0 5’ 1 24 0 5’ 1 24 Time after 1 Gy IR (h)
p=6.00e-11 p=5.31e-119
p=2.47e-111
S U P P L E M E N TA RY I N F O R M AT I O N
4 WWW.NATURE.COM/NATURECELLBIOLOGY
Supplementary Figure 4 Characterization of SCAI-/- mice and MEFs. a. Proliferation of MEFs. Primary WT (n = 9 biologically independent samples from 3 cell lines) and SCAI-/- (n = 12 biologically independent samples from 4 cell lines) MEFs were plated at passages 2, 3, 4 and 5, and trypsinized, counted and replated every second day. Values indicate the mean and error bars are the standard deviation. b. Overall DSB repair proficiency of 3 immortalized pairs of WT and SCAI-/- MEF cell lines was evaluated by enumeration of residual 53BP1 foci in G2 phase (H3-pS10-positive) cells at the indicated times after exposure to IR (2 Gy). Values indicate the mean and error bars the standard deviation across 3 independent experiments. P-value was calculated from a one-tailed t-test using Welch correction (n = 9 independent measurements across 3 MEF lines). Bars indicate mean ± SD. IRIF: Ionizing Radiation Induced Foci. c. Examples of cells from the experiment in (b). MEFs were fixed 8 h after exposure to IR (2 Gy), immunostained with antibodies to 53BP1 and H3-pS10 and counterstained for nuclear content with DAPI. d. 12 WT and 16 SCAI-/- age-matched male mice were subjected to whole-body gamma-irradiation with a one-time dose of 8 Gy. Survival was monitored over a 28-day period, after which remaining animals were euthanized. e. As in (d) but with female mice . 7 WT and 6 SCAI-/- mice were used. Data from (d) and (e) have been combined in Figure
3b. f. Primary B cells isolated from WT and SCAI-/- mice were labeled with CellTrace Violet and analyzed by flow cytometry to monitor cell proliferation by dye dilution. g. Flow cytometric quantification of splenic B220+IgM+ B cell populations from one WT and one SCAI-/- mouse. A representative of multiple mice. h. Graphical representation of B220+CD19+ total B cell number from 6 WT and 6 SCAI-/- mice. i. B cells isolated from 6 WT and 6 SCAI-/- mice were stimulated for 4 days to undergo IgH class-switching and IgG1 (left) and IgG3 (right) frequencies were measured by flow cytometry. j. Serum levels of IgG1, IgG3, and IgM immunoglobulins in 6 WT and 6 SCAI-/- mice as measured by ELISA. Each dot in the quantifications in (h), (i) and (j) represents data from individual mice and all lines indicate the mean. For each genotype, 3 males and 3 females were analyzed. k. Breeding experiment of WT (male n=19 and female n=15 animals) and SCAI-/- (male n=7 and female n=4 animals) mice. Quantification of litter sizes. Bars indicate mean ± SD and P-value was calculated with a two-tailed t test. Source data in Table S2. l. Spermatocyte spreads from WT and SCAI-/- mice were stained with SYCP3 and DMC1 antibodies. Representative pachynema spermatocytes are shown. Quantified in Figure 3j. m. Examples of the types of chromosomal aberrations observed in SCAI-/- B cells treated with PARP inhibitor and quantified in Figure 3m.
Cell divisions
0 1 2 3 4
>5 Cell divisions
0 1 2 3 4
>5
WT SCAI-/-
Num
ber o
f cel
ls
IgM
B220
56.4 56.8WT SCAI-/-
Day0 p
:2
Day2 p
:2
Day4 p
:2
Day2 p
:3
Day4 p
:3
Day2 p
:4
Day4 p
:4
Day2 p
:5
Day4 p
:5105
106
107
108
num
ber o
f cel
ls
wtScai-/-SCAI-/-WT
WT SCAI-/- WT SCAI-/-0
5
10
15
litte
r siz
e
male female
*p=0.022
CTB CSB RadialTrans-
locationComplexstructures
a
MEFs + IR (2 Gy, 8 h)WT SCAI-/-
H3-
pS10
53BP
1DA
PIm
erge
k
d e
SCP3/DMC1
WT SCAI-/-
SCP3/DMC1
DMC1 DMC1
f
0 0.5 80
20
40
60
80
Time after 2 Gy IR (h)
Av. #
53B
P1 IR
IF in
G2
cells SCAI WT 4
SCAI WT 6SCAI WT 8SCAI KO 1SCAI KO 2SCAI KO 5
SCAI WT 4SCAI WT 6SCAI WT 8
SCAI KO 1SCAI KO 2SCAI KO 5SCAI WT 4SCAI WT 6SCAI WT 8WT #4
WT #6WT #8SCAI-/- #1SCAI-/- #2SCAI-/- #5 P=0.0001
Hansen et al, Figure S4b
c
WT SCAI-/-0
100
200
300
400
Seru
m c
once
ntra
tion
[ug/
ml]
WT SCAI-/-0
100
200
300
400
500
Seru
m c
once
ntra
tion
[ug/
ml] IgG1 IgG3
WT SCAI-/-0
50
100
150
Seru
m c
once
ntra
tion
[ug/
ml] IgM
WT SCAI-/-0
2
4
6
8
10
IgG
3 fre
quen
cy [%
]
WT SCAI-/-0
10
20
30
40
50
IgG
1 fre
quen
cy [%
]
WT SCAI-/-0
2 107
4 107
6 107
B220
+CD
19+
cell n
umbe
r
j
i
0 5 10 15 20 25 300
20
40
60
80
100
Days elapsed%
sur
viva
l
SCAI-/-WT
femalefemale
0 5 10 15 20 25 300
20
40
60
80
100
Days elapsed
% s
urvi
val
SCAI-/-WT
male + female
0 5 10 15 20 25 300
20
40
60
80
100
Days elapsed
% s
urvi
val
SCAI-/-WT
malemale
0 5 10 15 20 25 300
20
40
60
80
100
Days elapsed
% s
urvi
val
SCAI-/-WT
male + female
h l
m
g
S U P P L E M E N TA RY I N F O R M AT I O N
WWW.NATURE.COM/NATURECELLBIOLOGY 5
Supplementary Figure 5 SCAI promotes DSB repair in heterochromatin. a. GFP-SCAI was affinity-purified on GFP-Trap beads from chromatin-enriched fractions of U2OS and U2OS/GFP-SCAI cells, and co-purifying proteins and input lysates were analyzed by immunoblotting with antibodies against HP1γ, GFP and Tubulin. b. As in (a), except that co-purifying proteins and input lysates were analyzed with antibodies against HP1β, GFP and Tubulin. c. Extended version of Figure 4a. Independent and immortalized WT and SCAI-/- MEF cell lines were arrested in G0/G1 by growing to full confluency. Cultures were mock-treated or exposed to IR (2 Gy), fixed either 0.5 or 24 h later and stained with 53BP1 antibody. Images were acquired as Z-stacks and the number of 53BP1 foci per cell was counted through the entire nuclear volume. Bars indicate mean ± SD (n = 9 independent measurements across 3 MEF lines). IRIF: Ionizing Radiation Induced Foci d. Extended version of (Figure 4b). Immortalized WT and SCAI-/- MEFs were grown to full confluency while transfecting with 53BP1 siRNA for 72 h or incubating with ATM inhibitor for 1 h prior to irradiation. Cells were treated and analyzed as in (c), except that they were immunostained for γ-H2AX as a marker of unrepaired DSB. (n = 3 biologically independent samples). e. Immortalized WT and SCAI-/- MEFs were treated and analyzed as in (c), except that cells were incubated with ATM inhibitor and co-stained with antibodies to γ-H2AX and the heterochromatin marker H3K9me3 to determine chromatin context (n = 3 biologically independent samples). HC (heterochromatin). f. Representative images from the analysis in (Figure 4e,f). g. Mouse NIH-3T3 fibroblasts were transfected with GFP-SCAI, CAS9 and guide RNA (gRNA) targeting the major satellite repeats
in heterochromatin containing chromocenters. Cells were fixed after 16 h and immunostained with 53BP1 antibodies and DNA stain DAPI. h. Immortalized WT and SCAI-/- MEFs were transfected with Cas9-GFP and gRNAs targeting the major satellite repeats to induce CRISPR-mediated DSBs in heterochromatin-containing chromocenters. After 8 h cells were fixed and immunostained with antibodies against H3K9me3. Cells were analyzed by high content microscopy using DAPI signal as a mask for chromocenters. 220 cells (n=220 independent measurements) were measured per condition and P-values were calculated from two-tailed t-tests using Welch correction. Centre indicates the median and whiskers the borders of the 95% quantiles. Y-axis on the left side corresponds to the non-transfected conditions, while y-axis on the right side corresponds to the transfected conditions. i. As in (h), except cells were immunostained with HP1β antibodies. (n=120 independent measurements) j. As in (h), except cells were immunostained with HP1γ antibodies. (n=130 independent measurements) k. As in (h), except cells were only stained with DAPI. (n=320 independent measurements) l. Cells from (g) were treated with ATM inhibitor and transfected as in (g) to induce heterochromatin associated DSBs by CRISPR. Lysates were analyzed for markers of ATM signaling by immunoblotting with the indicated antibodies. m. WT and SCAI-/- MEFs were exposed to ionizing radiation (IR, 1Gy) to induce DSBs predominantly in euchromatin. Lysates were collected at the indicated time points and analyzed for markers of ATM signaling by immunoblotting with the indicated antibodies. All scale bars, 10 μm. Uncropped blots (a,b,l,m) are shown in Figure S6.
0 0.5 240
20
40
60
Time after 3Gy IR (h)
Av. #
H2A
X IR
IF in
G0/
G1
cells
SCAI +/+, siMMSCAI -/-, siMMSCAI +/+, ATMiSCAI -/-, ATMiSCAI +/+, si53BP1SCAI -/-, si53BP1
0
5
10
15
Av. #
H2A
X IR
IF in
G0/
G1
cells
SCAI +/+, siMMSCAI -/-, siMMSCAI +/+, ATMiSCAI -/-, ATMiSCAI +/+, si53BP1SCAI -/-, si53BP1
0
5
10
15
Av. #
H2A
X IR
IF in
G0/
G1
cells
SCAI +/+, siMMSCAI -/-, siMMSCAI +/+, ATMiSCAI -/-, ATMiSCAI +/+, si53BP1SCAI -/-, si53BP1
0
5
10
15
Av. #
H2A
X IR
IF in
G0/
G1
cells
SCAI +/+, siMMSCAI -/-, siMMSCAI +/+, ATMiSCAI -/-, ATMiSCAI +/+, si53BP1SCAI -/-, si53BP1
0
5
10
15
Av. #
H2A
X IR
IF in
G0/
G1
cells
SCAI +/+, siMMSCAI -/-, siMMSCAI +/+, ATMiSCAI -/-, ATMiSCAI +/+, si53BP1SCAI -/-, si53BP1
SCAI-/-, siCTRLWT, siCTRL
WT, ATMi
WT, si53BP1SCAI-/-, ATMi
SCAI-/-, si53BP1
a b
m
WC
E
pATM(S1981)
pKAP1(S824)
h after IR (1Gy)
WT SCAI-/-
H2AXKAP1
Tubulin
0 10.5 2 3
ATM
0 10.5 2 3
55-17-
117-
110-365-
370-
NIH
-3T3
+gRN
A-C
AS9
53BP1 GFP-SCAI mergeDAPI
HP1
Tubulin
GFP-SCAIIn
put
PD: G
FP
HP1
U2O
S/G
FP-S
CAI
U2O
S
e
f
g
h i
0
2 106
4 106
6 106
0
2 107
4 107
6 107
Inte
nsity
at c
hrom
ocen
ters
Non-transfected Transfected(CAS9-GFP+gRNA)
WT WTSCAI-/- SCAI-/-
H3K9me3
Non-transfected Transfected(CAS9-GFP+gRNA)
WT WTSCAI-/- SCAI-/-0
2 106
4 106
6 106
8 106
1 107
02 107
4 107
6 107
8 107
1 108
Inte
nsity
at c
hrom
ocen
ters HP1
j k
50-90-25-25-
50-
HP1
Inpu
tPD
: GFP
HP1
U2O
S/G
FP-S
CAI
U2O
S
GFP-SCAITubulin
90-25-25-
+DAPI
pKAP-1
siCTRL siRNF8 siSCAI8Gy 24h 3Gy 24h 3Gy 24h 8Gy 24h
5-10 IRIF 8-12 IRIF 3-10 IRIF 8-20 IRIF
H2AX
0 0.5 240
20
40
60
Time after 2 Gy IR (h)
Av. #
53B
P1 IR
IF in
G0/
G1
cells
SCAI WT 4SCAI WT 6SCAI WT 8SCAI KO 1SCAI KO 2SCAI KO 5
SCAI WT 4SCAI WT 6SCAI WT 8
SCAI KO 1SCAI KO 2SCAI KO 5SCAI WT 4SCAI WT 6SCAI WT 8WT #4
WT #6WT #8SCAI-/- #1SCAI-/- #2SCAI-/- #5
Non-transfected Transfected(CAS9-GFP+gRNA)
WT WTSCAI-/- SCAI-/-
DAPI area
0
50
100
150
200
250
0
50
100
150
200
250
DAPI area
Area
of c
hrom
ocen
ters
c
pKAP1S824CAS9
pATMS1981
H2AXTubulin
CAS9-mCherry-gRNA
NIH3T3
GFP-SCAI
16h
+ + + + + +
+ + ATMi
GFP-SCAI
55-
117-370-
17-
190-
90-
l
Hansen et al, Figure S5
d
0
2 106
4 106
6 106
0
1 107
2 107
3 107
4 107
Inte
nsity
at c
hrom
ocen
ters
Non-transfected Transfected(CAS9-GFP+gRNA)
WT WTSCAI-/- SCAI-/-
HP1
0 0.5 240
10
20
30
40
50
60
70
Time after 3Gy IR (h)Av
. # IR
IF in
G0/
G1 c
ells
n.s
Total - WTTotal - SCAI-/-HC - WT
0 0.5 240
10
20
30
40
50
60
Time after 3Gy IR (h)
Av. #
IRIF
Total - WTTotal - SCAI-/-
HC - WTHC - SCAI-/-
0 0.5 240
10
20
30
40
50
60
Time after 3Gy IR (h)
Av. #
IRIF
Total - WTTotal - SCAI-/-
HC - WTHC - SCAI-/-
0 0.5 240
10
20
30
40
50
60
Time after 3Gy IR (h)
Av. #
IRIF
Total - WTTotal - SCAI-/-
HC - WTHC - SCAI-/-
0 0.5 240
10
20
30
40
50
60
Time after 3Gy IR (h)
Av. #
IRIF
Total - WTTotal - SCAI-/-
HC - WTHC - SCAI-/-HC - SCAI-/-
n.s
+ATMi
S U P P L E M E N TA RY I N F O R M AT I O N
6 WWW.NATURE.COM/NATURECELLBIOLOGY
Figure 1e
53BP1
SCAI
53BP1
SCAI
pKAP1S824 98-
50-
64- 148-
250-
50-
64- 148- 250-
Figure 1f
GST
FLAG
GST
FLAG
191-
62-
98-
49-
Figure 1i
64-
98-
148-
250-
GFP
GFP
HA
64-
98-
64-
98-
Figure 1j 53BP1
GFP
GFP
53BP1
64-
98-
64-
98-
148-
250-
148-
250-
Figure 4d
97-
97-
97-
97-
97-
97-
pKAP1S824 KAP1
1
MCM6
SCAI
Figure 3a
240bp
218bp
Figure 3a
Hansen et al, Figure S6
Supplementary Figure 6 Uncropped western blots from all main and supplementary figures
S U P P L E M E N TA RY I N F O R M AT I O N
WWW.NATURE.COM/NATURECELLBIOLOGY 7
Figure 5f
15-
25-
55-
250-
100- 130-
100- 130-
250-
KAP1
pATMS1981
pKAP1S824 GFP
γH2AX Tubulin
Figure S2f
188 98
62
49
38 28
17 14
6 GST Figure S3c
98-
64-
64-
50-
MCM6
SCAI
98
250-
Figure S1d
53BP1
HA
Figure S1g
98-
SCAI
MCM6
Figure S3b 53BP1
MCM6
250-
98-
Figure S1c
50-
Tubulin
SCAI
SP1
64-
2
Supplementary Figure 6 Continued
S U P P L E M E N TA RY I N F O R M AT I O N
8 WWW.NATURE.COM/NATURECELLBIOLOGY
Figure S5l
CAS9 250-
pKAP1S824
pATMS1981
GFP
γH2AX
Tubulin
250-
100- 130-
130-
100-
70-
15-
25-
55-
Figure S5m pATMS1981
pKAP1S824
ATM
KAP1
γH2AX
Tubulin
97-
250-
250-
Figure S5a
22
36
50
16
98
64
50 Tubulin
Figure S5b
36-
50-
22- 16-
36-
50-
22- 16-
98
64
50 Tubulin
GFP HP1γ
HP1γ
HP1β
GFP
3 Supplementary Figure 6 Continued
S U P P L E M E N TA RY I N F O R M AT I O N
WWW.NATURE.COM/NATURECELLBIOLOGY 9
Live-‐born pups SCAI+/+ SCAI+/-‐ SCAI-‐/-‐ Total
Observed 27 75 29 131
32.75 65.5 32.7525% 50% 25%
Expected
Supplementary Table 1 Breeding of SCAI-/- mice. Table showing the expected and observed genotypes of 3-week old pups from SCAI+/- intercross breedings.
S U P P L E M E N TA RY I N F O R M AT I O N
10 WWW.NATURE.COM/NATURECELLBIOLOGY
WT male SCAI-/- male WT female SCAI-/- female
x x x xWT female WT female WT male WT male
#1 & 2 34 20 #9 & 10 23 8#3 & 4 36 18 #11 &12 26 0#5 & 6 25 0 #13 & 14 30 5#7 & 8 20 0 #15 & 16 22 0
Total live-born pups 115 38 Total live-
born pups 101 13
Breeding cage
Breeding cage
Supplementary Table 2 Fertility measurements of SCAI-/- mice. Number of live-born pups from breeding cages containing one male and one female mouse of the indicated genotypes. Four breeding cages were set up to test fertility of SCAI-/- males along with four additional breeding cages using WT littermates as the control group. Similar experimental and control groups were setup to test fertility of SCAI-/- females. All mating experiments lasted at least six months.
S U P P L E M E N TA RY I N F O R M AT I O N
WWW.NATURE.COM/NATURECELLBIOLOGY 11
Genotype# Aberrant
metaphases (%) # CTB # CSB # Radial # Translocation # Other aberations# Metaphases
analyzedWT #1 6 (7.5%) 2 4 1 0 0 80WT #2 5 (6.3%) 1 2 2 0 0 80WT #3 5 (6.3%) 0 4 0 1 0 80WT #4 4 (5.9%) 3 1 0 0 0 68WT #5 2 (2.8%) 2 0 0 0 0 72WT #6 4 (5.6%) 4 0 0 0 0 72
Total WT 26 (5.8%) 12 11 3 1 0 452SCAI-/- #1 15 (19%) 4 8 2 2 2 79SCAI-/- #2 11 (13.8%) 4 6 1 1 0 80SCAI-/- #3 15 (18.8%) 3 8 2 4 0 80SCAI-/- #4 8 (11.1%) 6 2 0 0 0 72SCAI-/- #5 7 (9.7%) 5 11 0 1 0 72SCAI-/- #6 9 (12.9%) 10 2 0 0 0 70
Total SCAI-/- 65 (14.3%) 32 37 5 8 2 453
Genotype# Aberrant
metaphases (%) # CTB # CSB # Radial # Translocation # Other aberations# Metaphases
analyzedWT #1 1 (2%) 0 0 0 1 0 49
WT #2 5 (8.6%) 2 4 0 0 0 58
WT #3 5 (8.6%) 2 4 0 0 0 58
Total WT 11 (6.7%) 4 8 0 1 0 165SCAI-/- #1 5 (8.6%) 2 4 0 0 0 58
SCAI-/- #2 5 (8.6%) 2 4 0 0 0 58
SCAI-/- #3 9 (12.3%) 2 7 0 0 0 73
Total SCAI-/- 19 (10.1%) 6 15 0 0 0 189
Chromosomal instability in B cells treated with PARPi
Chromosomal instability in B cells treated with DMSO
Supplementary Table 3 Genomic instability in SCAI-/- B cells. Frequencies of chromosomal aberrations in primary murine B cells, stimulated with LPS/IL4/RP105 to undergo IgG1 class switching for 72 hours, and treated with DMSO or PARP inhibitor olaparib (2 µM) for 16 h. Quantifications and classifications are displayed graphically in (Fig. 3m; Fig. S4m).
S U P P L E M E N TA RY I N F O R M AT I O N
12 WWW.NATURE.COM/NATURECELLBIOLOGY
References
1 Raschle, M. et al. DNA repair. Proteomics reveals dynamic assembly of repair complexes during bypass of DNA cross-links. Science 348, 1253671, doi:10.1126/science.1253671 (2015).